Tag - pharmaceuticals

 
Menu
Search
 
May 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
ASIA PACIFIC
Jan 16, 2023
In China, no easy way to get Pfizer's COVID drug Paxlovid
Beijing has acknowledged that supplies are still insufficient to meet demand, even as millions of courses of the treatment were shipped to the country recently.
Japan Times
WORLD / Science & Health
Jan 14, 2023
Pfizer's bivalent vaccine linked to rare strokes in older people in preliminary U.S. data
The early finding still needs more investigation, and recommendations for the vaccine have not been changed, a statement by the U.S. Food and Drug Administration said.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
JAPAN
Jan 11, 2023
Health ministry suggests restricting bulk drug purchases amid hoarding fears
The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.
Japan Times
BUSINESS / Markets
Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
Japan Times
WORLD / Science & Health
Jan 7, 2023
Alzheimer’s drug made jointly by Japan's Eisai wins accelerated U.S. approval
The U.S. has called the drug 'an important advancement in the ongoing fight' against the debilitating disease. But its $26,000 price tag could put it out of reach for many.
Japan Times
ASIA PACIFIC / Science & Health
Jan 7, 2023
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
Japan Times
BUSINESS / Companies
Jan 6, 2023
Shionogi's COVID-19 pill may get China approval in March
The Japanese drugmaker has been submitting data to regulators in China and expects Xocova to be authorized for use as early as this quarter, Chief Executive Officer Isao Teshirogi said.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
ASIA PACIFIC
Dec 30, 2022
China's COVID wave sparks scramble for vital drugs across Asia
Beijing's decision to abruptly remove most pandemic restrictions with little preparation is driving an unprecedented number of cases, leaving hospitals and funeral homes overwhelmed.
Japan Times
BUSINESS / Companies
Dec 28, 2022
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer's biomarkers in blood tests.
Japan Times
JAPAN / Science & Health
Dec 25, 2022
Japan medical bodies aim to develop tailored drugs to treat rare diseases
Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
WORLD / Science & Health
Dec 22, 2022
Injectable HIV treatment offers hope to Ugandan patients
Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.
Japan Times
BUSINESS / Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Japan Times
BUSINESS
Dec 13, 2022
Johnson & Johnson's Japan unit searched over alleged antitrust violation
The Japan Fair Trade Commission suspects Johnson & Johnson K.K. and ASP Japan of obstructing competitors' sales of cleaners and disinfectants for endoscopes.
Japan Times
JAPAN / Science & Health
Dec 13, 2022
Shionogi says Japan government to buy 1 million more COVID pill doses
The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
WORLD / Science & Health
Nov 25, 2022
Researchers test mRNA technology for universal flu vaccine
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
Japanese stripper bids to have her porn movies taken off internet
Plaintiff Miyuki Ariga (left) speaks at a news conference along with her lawyer, Yoshitomo Morohashi, after filing a lawsuit at the Tokyo District Court on Monday.
Kishida defends planned rule to revoke foreigners' residency
Prime Minister Fumio Kishida speaks during a meeting of the Lower House Judicial Affairs Committee on Wednesday.
Human bone-like objects found at Nippon Steel plant’s molten iron pot, with one worker missing
Police believe it’s highly possible that human bones found in a molten iron pot at Nippon Steel's Oita factory belong to a missing male employee.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Man suspected of using smart glasses to cheat on Waseda University exams
The Waseda University campus in Tokyo. An 18-year-old male test-taker is suspected of using smart glasses to cheat during the university's entrance exam.
Japanese rap creates its mecca in Pop Yours
Tokyo-based artist Jumadiba says he forgoes the label of simply “rap” for his music because the Japanese rap scene isn’t confined to a particular sound.
Who’s toughest on China? Biden’s tariff tactic ups ante as election looms.
U.S. President Joe Biden speaks about new actions to protect American workers and businesses from China's "unfair" trade practices, in the Rose Garden of the White House in Washington on Tuesday.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Ishin struggles to set itself apart from other parties
Nippon Ishin no Kai Secretary-General Fumitake Fujita (right) speaks beside Yui Kanazawa, the party's candidate in the Tokyo 15th district by-election on April 28. Nippon Ishin lost in this by-election as well as another in Nagasaki held on the same day.
In Japan, 68,000 people over 65 projected to die alone at home this year
As Japan grapples with its population's rapid aging, supporting people who live and age alone is looming larger on the policy agenda.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan
By Mai Yoshikawa

SUSTAINABLE JAPAN

Live like a lord or lady for a night at Ozu Castle
Live like a lord or lady for a night at Ozu Castle

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER